Amrutanjan Health Care Limited

AMRUTANJAN

INE098F01031

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:49 28/05/2024 BST			5-day change	1st Jan Change
696.4 ^INR	+0.16%		-6.29%	+16.13%

05-23	Amrutanjan Health Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
05-23	Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2023-24	CI

Amrutanjan Health Care Limited Appoints Meenalochani Raghunathan as an Additional Director

August 12, 2022 at 01:35 pm

Amrutanjan Health Care Limited at the Board of Directors meeting held on August 12, 2022, approved appointment of Ms. Meenalochani Raghunathan as an Additional Director (Non-Executive Independent) on the Board of the Company with effect from August 12, 2022.

Latest news about Amrutanjan Health Care Limited

Amrutanjan Health Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-23	CI
Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2023-24	05-23	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09	CI
Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2023-24	02-09	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-10	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-10	CI
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2023-2024	11-10	CI
Amrutanjan Health Care Limited Declares Final Dividend for the Year Ended March 31, 2023	21/09/23	CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023.	02/08/23	CI
Amrutanjan Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	02/08/23	CI
Tranche Update on Amrutanjan Health Care Limited's Equity Buyback Plan announced on June 30, 2023.	02/08/23	CI
Amrutanjan Health Care Limited's Equity Buyback announced on June 30, 2023, has closed with 320,000 shares, representing 1.09% for INR 288 million.	24/07/23	CI
Amrutanjan Health Care Gets Board's Nod to Buy Back Up to INR288 Million Worth of Shares; Shares Surge 12%	30/06/23	MT
Amrutanjan Health Care Limited Announces Board Changes	30/06/23	CI
Amrutanjan Health Care Limited announces an Equity Buyback for 320,000 shares, representing 1.09% for INR 288 million.	30/06/23	CI
Amrutanjan Health Care Limited authorizes a Buyback Plan.	29/06/23	CI
Amrutanjan Health Care Limitedâ€™sÂ Board intends to launch an Equity Buyback onÂ June 30, 2023.	28/06/23	CI
Amrutanjan Health Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	31/05/23	CI
Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2022-2023	30/05/23	CI
Amrutanjan Health Care Limited Announces Demise of Pasumarthi Sathyanarayana Murthi, Non-Executive Non Independent Director	10/04/23	CI
India's Amrutanjan Health Care sinks on whistleblower allegations	15/02/23	RE
Amrutanjan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Amrutanjan Health Care Limited Declares Interim Dividend for the Financial Year 2022-23	14/02/23	CI
INDIA STOCKS-Indian shares may open higher, tracking Asia, lower oil prices	07/11/22	RE
Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2022-23	04/11/22	CI

Chart Amrutanjan Health Care Limited

Duration

Period

More charts

Company Profile

Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene. Its segments include OTC Products, Beverages, and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Companyâs pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. The Companyâs beverages include Fruitnik and Fruitnik Electro+.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AMRUTANJAN HEALTH CARE LIMITED	+16.13%	242M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.31%	42.32B
OTSUKA HOLDINGS CO., LTD.	+16.32%	21.29B
SANDOZ GROUP AG	+19.33%	15.29B
CIPLA LIMITED	+18.71%	14.36B
ZYDUS LIFESCIENCES LIMITED	+52.78%	12.81B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.24%	6.58B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.64%	5.51B